Seawolf launches with $100M to make non-viral gene therapies
A San Diego startup believes it’s made big progress in one of the great unsolved technical challenges of the gene therapy field: safely and effectively delivering DNA without a virus. Seawolf Therapeutics, which has operated ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.